Most of the genes involved in the VUS were obesity-related ciliopathies (16/28, 57%), followed by the cell-signaling regulation genes (6/28, 21%), leptin signaling pathway (3/28, 11%), and unknown mechanisms (3/28, 11%) (Figure 1). The gene discussed is LEP; the disease is obesity disorder.